Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125194873 | 12519487 | 3 | F | 20160820 | 20160630 | 20160902 | EXP | FR-TEVA-671909ISR | TEVA | AMAZAN E. MYCOPHENOLATE MOFETIL/PREDNISONE/ TACROLIMUS PHAEOHYPHOMYCOSIS: CASE REPORT VOL 1606 PAGE 121, 2016. REACTIONS WEEKLY. 2016 JAN 01;. | 59.00 | YR | M | Y | 0.00000 | 20160902 | OT | FR | FR |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125194873 | 12519487 | 1 | PS | MYCOPHENOLATE MOFETIL. | MYCOPHENOLATE MOFETIL | 1 | Unknown | 2 GRAM DAILY; | U | 65457 | |||||||||
| 125194873 | 12519487 | 2 | I | PREDNISONE. | PREDNISONE | 1 | Unknown | 10 MILLIGRAM DAILY; | U | 0 | |||||||||
| 125194873 | 12519487 | 3 | I | TACROLIMUS. | TACROLIMUS | 1 | Unknown | 3.5 GRAM DAILY; | Y | 0 | |||||||||
| 125194873 | 12519487 | 4 | I | TACROLIMUS. | TACROLIMUS | 1 | Unknown | 3.5 G DAILY | Y | 0 | |||||||||
| 125194873 | 12519487 | 5 | I | ITRACONAZOLE. | ITRACONAZOLE | 1 | Unknown | 300 MILLIGRAM DAILY; | Y | 0 | |||||||||
| 125194873 | 12519487 | 6 | I | ITRACONAZOLE. | ITRACONAZOLE | 1 | Unknown | 400 MILLIGRAM DAILY; | Y | 0 | |||||||||
| 125194873 | 12519487 | 7 | I | posaconazole | POSACONAZOLE | 1 | Unknown | 800 MILLIGRAM DAILY; | U | 0 | |||||||||
| 125194873 | 12519487 | 8 | C | amoxicillin, clavulanic acid | AMOXICILLINCLAVULANIC ACID | 1 | Unknown | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 125194873 | 12519487 | 1 | Immunosuppressant drug therapy |
| 125194873 | 12519487 | 2 | Immunosuppressant drug therapy |
| 125194873 | 12519487 | 3 | Immunosuppressant drug therapy |
| 125194873 | 12519487 | 4 | Immunosuppressant drug therapy |
| 125194873 | 12519487 | 5 | Phaehyphomycosis |
| 125194873 | 12519487 | 7 | Phaehyphomycosis |
| 125194873 | 12519487 | 8 | Phaehyphomycosis |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 125194873 | 12519487 | HO |
| 125194873 | 12519487 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 125194873 | 12519487 | Abscess | |
| 125194873 | 12519487 | Condition aggravated | |
| 125194873 | 12519487 | Drug interaction | |
| 125194873 | 12519487 | Immunosuppressant drug level increased | |
| 125194873 | 12519487 | Pain | |
| 125194873 | 12519487 | Phaehyphomycosis | |
| 125194873 | 12519487 | Purulent discharge |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |